Evidence map›Paper›PMID 36276718›Full record

ArticleHeliyon2022

Current research and clinical trends in rosacea pathogenesis.

Xi-Min Hu, Zhi-Xin Li, Dan-Yi Zhang, Yi-Chao Yang, Sheng-Yuan Zheng, Qi Zhang, Xin-Xing Wan, Ji Li, Rong-Hua Yang, Kun Xiong

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Postepy dermatologii i alergologii · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Current Trends and Future Insights on Rosacea Treatment: A Bibliometric Analysis.Clinical, cosmetic and investigational dermatology · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. A bibliometric analysis of apoptosis in glaucoma.Frontiers in neuroscience · 2023
    Article
  17. Review
  18. The Role of Cosmetology in an Effective Treatment of Rosacea: A Narrative Review.Clinical, cosmetic and investigational dermatology · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xi-Min HuDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China.
Zhi-Xin LiXiangya School of Medicine, Central South University, Changsha, 410013, China.
Dan-Yi ZhangXiangya School of Medicine, Central South University, Changsha, 410013, China.
Yi-Chao YangXiangya School of Medicine, Central South University, Changsha, 410013, China.
Sheng-Yuan ZhengXiangya School of Medicine, Central South University, Changsha, 410013, China.
Qi ZhangDepartment of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, 410013, China.
Xin-Xing WanDepartment of Endocrinology, Third Xiangya Hospital, Central South University, Changsha, 410013, China.
Ji LiDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China.
Rong-Hua YangDepartment of Burn and Plastic Surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China.
Kun XiongDepartment of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, 410013, China.
Central South University · CNGuangzhou First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rosacea is a common and complex chronic inflammatory skin disorder, the pathophysiology and etiology of which remain unclear. Recently, significant new insights into rosacea pathogenesis have enriched and reshaped our understanding of the disorder. A systematic analysis based on current studies will facilitate further research on rosacea pathogenesis. Objective: To establish an international core outcome and knowledge system of rosacea pathogenesis and develop a challenge, trend and hot spot analysis set for research and clinical studies on rosacea using bibliometric analysis and data mining. Methods: A search of the WoS, and PubMed, MEDLINE, Embase and Cochrane collaboration databases was conducted to perform visual bibliometric and data analysis. Results: A total of 2,654 studies were used for the visualization and 302 of the 6,769 outcomes for data analysis. It reveals an increased trend line in the field of rosacea, in which its fast-growing pathogenesis attracted attention closely related to risk, comorbidity and therapeutic strategies. The rosacea pathogenesis has undergone the great development on immunology, microorganisms, genes, skin barriers and neurogenetics. The major of studies have focused on immune and microorganisms. And keyword visualization and data analyses demonstrated the cross-talk between cells or each aspect of pathogenesis, such as gene-gene or gene-environment interactions, and neurological mechanisms associated with the rosacea phenotype warrant further research. Limitations: Inherent limitations of bibliometrics; and reliance on research and retrospective studies. Conclusions: The understanding of rosacea's pathogenesis has been significantly enhanced with the improved technology and multidisciplinary integration, but high-quality, strong evidence in favor of genomic and neurogenic requires further research combined with a better understanding of risks and comorbidities to guide clinical practice.

Indexed as

Bibliometric analysisComorbidityData mining studyPathogenesisRisk factorsRosaceaTreatment

Identifiers

PMID36276718
PMCPMC9578998
OpenAlexW4304892800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.